About the Authors

Daniel Johnstone

Affiliations Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine, The University of Newcastle, Callaghan, New South Wales, Australia, School of Electrical Engineering and Computer Science, The University of Newcastle, Callaghan, New South Wales, Australia

Elizabeth A. Milward

Affiliations Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine, The University of Newcastle, Callaghan, New South Wales, Australia, School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, New South Wales, Australia

Regina Berretta

Affiliations Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine, The University of Newcastle, Callaghan, New South Wales, Australia, School of Electrical Engineering and Computer Science, The University of Newcastle, Callaghan, New South Wales, Australia

Pablo Moscato

Pablo.Moscato@newcastle.edu.au

Affiliations Priority Research Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine, The University of Newcastle, Callaghan, New South Wales, Australia, School of Electrical Engineering and Computer Science, The University of Newcastle, Callaghan, New South Wales, Australia

for the Alzheimer's Disease Neuroimaging Initiative

Competing Interests

ADNI was funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKilne, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AD, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Public access to the data exists since Nov. 19th, 2010. The authors refer to: http://adni.loni.ucla.edu/2010/11/new-set-of-proteomics-data-will-be-available-friday-november-19th/ for more information.

Author Contributions

Conceived and designed the experiments: DJ EAM PM. Performed the experiments: DJ PM. Analyzed the data: DJ EAM RB PM. Contributed reagents/materials/analysis tools: RB. Wrote the paper: DJ EAM PM.